Sargramostim Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 250 mcg/5 mL
Reference Brands: Leukine (USA/EU)
Category: Critical Care
Sargramostim is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) used to stimulate the production of white blood cells. It is prescribed to patients undergoing bone marrow transplantation, chemotherapy, or with severe neutropenia to reduce infection risk. Administered via subcutaneous or intravenous injection, sargramostim helps accelerate bone marrow recovery and improve immune function. Sargramostim is available in Injection and strengths such as 250 mcg/5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sargramostim is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Sargramostim can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Sargramostim is used to help the bone marrow recover and produce white blood cells after chemotherapy, bone‑marrow transplantation, or stem‑cell transplant. It is also used to reduce the risk of infection in patients with low white blood cell counts (neutropenia).
Sargramostim is a recombinant human granulocyte‑macrophage colony‑stimulating factor (GM‑CSF), produced by recombinant DNA technology in yeast cells.
One common trade name of Sargramostim is Leukine.
Sargramostim (Leukine) is produced and marketed by various pharmaceutical companies globally; originally developed by a company called Immunex.
The generic name is Sargramostim.
A brand name is Leukine.
Sargramostim is manufactured via recombinant yeast‑cell processes; specific manufacturing sites vary depending on the country and manufacturer.
Related Products
Somatrogon‑Ghla
Strength:
24 mg/1.2 mL, 60 mg/1.2 mL
Form: injection (prefilled syringe)
Reference Brands: Ngenla (USA)
View Details
Methimazole
Strength:
5 mg, 10 mg
Form: Tablets
Reference Brands: Tapazole (USA), Northyx (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
